Slide 1: Uscom Annual Results FY 2016
Uscom (UCM) – Global Medical Devices For personal use only Annual Results FY 2016 Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Uscom Executive Chairman/CEO The Measure of Life
Slide 2: Disclaimer
Disclaimer For personal use only This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter. The information in this presentation, whether written or verbal, has been prepared without taking into account the commercial, fina
Slide 3: Uscom
Uscom For personal use only “Improving physician effectiveness and patient outcomes with practice changing noninvasive medical devices.” New generation digital cardiovascular and pulmonary devices. 3 Uscom – Medical devices the experts use
Slide 4: Uscom – 2016
Uscom – 2016 For personal use only Not only growth: Record revenue, sales, cash, share price, cap value (+44 to114%) But investment in the future: Transformational $65m 5yr agreement Acquired Thor laboratories and consolidated into Uscom Non recurring investment in: acquisition and integration (≈$1m
Slide 5: UCM – 2016 Results: Total Revenue
UCM – 2016 Results For personal use only Total Revenue $3,500,000 $2,936,504 $3,000,000 $2,500,000 $2,039,426 $2,000,000 $1,500,000 $1,377,716 $1,010,942 $1,000,000 $864,099 $500,000 $0 2012 2013 2014 2015 2016 2016 – Total revenue up 44% to $2.94m (43% CAGR for 3 years) 9 * Estimate Right company,
Slide 6: UCM – 2016 Results: Receipts from Customers
UCM – 2016 Results For personal use only Receipts from Customers 2,563,145 2,500,000 2,000,000 1,500,000 1,321,080 $ 1,000,000 829,424 621,253 500,000 - 2013 2014 2015 2016 2016 – Receipts from Customers up 94% to $2.56m (60% CAGR for 3 years) 9 * Estimate Right company, right time…..
Slide 7: UCM – 2016 Results: Cash, Equity and Assets
UCM – 2016 Results For personal use only Cash, Equity and Assets 6,000,000 5,711,746 4,937,991 5,000,000 4,000,000 2,839,773 2,936,355 2015 $ 3,000,000 2016 2,288,661 2,000,000 1,290,796 992,796 1,000,000 526,317 0 Cash Cash Spend Equity Assets 2016 – A year of investment 9 * Estimate Right company,
Slide 8: UCM – 2016 Results: Quarterly Revenue and Cash Receipts
UCM – 2016 Results For personal use only Quarterly Total Revenue Quarterly Cash Receipts 900000 700,000 800000 600,000 700000 600000 500,000 500000 400,000 $ $ 400000 300,000 300000 200,000 200000 100000 100,000 0 0 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Slide 9: UCM – 2016 Results: Growth
UCM – 2016 Results For personal use only UCM Growth FY 2016 UCM YTD 2016 120 114 100 80 61 % 60 81 67 % % 40 20 0 Share Price Cap value UCM share price +61% (15.5-25c) Cap value +114% ($12.2m-$27.1m) UCM continues to outperform the ASX and Health Sector 9 BellDirect 24th August 2016
Slide 10: UCM – 2016 Results: Share Price
UCM – 2016 Results For personal use only 2016 – Share Price 15.5 to 25 (+61%) To date – 15.5 to 32.5 (+110%) UCM FPO 2016 Record 2016 with two new product lines and CIIC agreement to impact in 2017 9 BellPotter 24th August 2016 July 2015 to June 2016
Slide 11: Performance FY2016
UCM – 2016 Results For personal use only Perfomance FY2016 Indices, Top 10 Superannuation funds and UCM 70 61 60 50 40 Indices Top 10 Super Funds 30 % Growth 20 16.3 10.6 10 7.6 7 5.9 5.7 5.5 5.5 5.4 5.1 5 4.5 0 -2.3 -10 -5.2 -7.5 -10.1 -20 -30 -25.8 -40 The Top 10 Australian Superannuation Funds, "
Slide 12: Uscom
Uscom For personal use only “Time and again we find similar traits among long-term winners: 1. Led by founders with their fortunes and legacies on the line 2. Debt free and scalable operations 3. Willing to disrupt themselves 4. Have zealous, loyal customers.” Joe Magyer Australian Financial Review
Slide 13: Uscom – 2016: What we did
Uscom – 2016 For personal use only What we did: A year of record growth (40-90%) $65m 5yr deal signed for 2017 (2016 rev $3m) Acquired and paid for Thor Laboratories Consolidated Thor and established global reporting Established a global corporate model Non recurring spend on acquisition and integra
Slide 14: Products USCOM 1A
Products USCOM 1A For personal use only Heart failure, hypertension, sepsis, fluid Non invasive, accurate, compact, platform technology Accurate cardiac output Works with all other hospital equipment Cardiac stroke volume Intuitive touch screen Systemic vascular Real time data resistance Platform te
Slide 15: New Products: Central Blood Pressure
New Products For personal use only Hypertension, heart failure and vascular disease Central Blood Pressure and Pulse Wave Analysis The new standard for hypertension • FDA, CE Mark, TGA approvals • Home or clinic • Supra-systolic • PPW Analysis Oscollometry • Results in • Reliable and 30 seconds • ac
Slide 16: New Products: Digital Ultrasonic Spirometry
New Products For personal use only Series Digital Ultrasonic Spirometry New Standards of Pulmonary Testing Devices Applications Software 16 For launch FY 2017 Uscom – Devices the experts use
Slide 17: New Products tSpiro
New Products tSpiro For personal use only Uscom sells technologies others are only researching High fidelity digital ultrasonic spirometers The future for asthma, COPD, occuational lung disease and eHealth, • CE, FDA and TGA. CFDA (in submission) • US revenue (more than 400 sold) • Software analytic
Slide 18: Uscom Global
1. Uscom Sydney 2. Uscom London Uscom Global 3. 4. Uscom Budapest Uscom LA For personal use only Delivering multiple products into multiple jurisdictions 5. Uscom Shanghai • • •• 2 • •• • •• 3 ••• •••4 •• • •• •• •• • • • • 5 • • • • Key Markets •• Asia • • • 1 Europe Nth America Focus FY 2017 Asia
Slide 19: China is Important
China is Important CIIC to distribute $65m of Uscom devices and support regulatory For personal use only State funded growth over 5 yrs China Health Expenditure as % of GDP China Health Spend (USD) 7.9 GDP=12,000,000,000,000 6.5 Health=5.4%=648,000,000,000 Objective=12%=1,400,000,000,000 5.4 4.8 4.8
Slide 20: CIIC China
CIIC China For personal use only “We plan to make Uscom one of the leading medical device brands in China over the next five years.” Daniel Sun, Head of BD and Marketing, Shanghai CIIC Science and Technology, Medical Device division 20 Uscom – Medical devices the experts use
Slide 21: CIIC China
CIIC China For personal use only http://www.bloomberg.com/news/articles/2016-07-05/china-inc-goes-on-a-buying-spree-for-global-health-care-assets 21 Uscom – Medical devices the experts use
Slide 22: Uscom CIIC China Agreement
Uscom CIIC China Agreement For personal use only 5 year importation and wholesale agreement with Shanghai CIIC Science and Technology Development Corp targeted to generate A$65m sales. CIIC S&T – State owned company CIIC revenue – $10b USD, Med Device Division $250m USD 22 Uscom – Medical devices th
Slide 23: Recent Media
Recent Media For personal use only Alan Kohler Peter Switzer Fox TV 23 CNBC Asia Tom Piotrowski Uscom – Medical devices the experts use
Slide 24: Recent Media
Recent Media For personal use only With improved operational performance has come increased media and international investor interest The Australian, 5-3-16 Sarah-Jane Tasker 24
Slide 25: Uscom – 2016
Uscom – 2016 For personal use only Not only growth: Record revenue, sales, cash, share price, cap value (+44 to114%) But investment in the future: Transformational $65m 5yr agreement Acquired Thor laboratories and consolidated into Uscom Non recurring investment in: acquisition and integration (≈$1m
Slide 26: UCM – 2016 Results
UCM – 2016 Results For personal use only " Investors can review Uscom’s progress in 2016 with satisfaction and look forward to the rewards of 2017 and beyond. Uscom has invested in the future, and an investment in Uscom is an investment in the future.” 26 Uscom – Medical devices the experts use
Slide 27: Uscom – 2017: What we are going to do
Uscom – 2017 For personal use only What we are going to do: Deliver two new revenue streams – BP+, SpiroSonic Increase sales to China through CIIC ($65m - 5 yrs) Early US and Euro BP+ and SpiroSonic sales Continue growing USCOM 1A sales Grow our distribution and marketing network 27 Uscom – Medical
Slide 28: Three world leading product ranges entering profit phase
Uscom – 2017 For personal use only Three world leading product ranges entering profit phase Global Profit Concept Product Pilot Validation Regulatory Revenue Distribution FY17 USCOM 1A ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓ Uscom BP+ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓ SpiroSonic ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Investment to Profit 26 IP transformed into
Slide 29: Regulatory approvals across jurisdictions in 2017
Uscom – 2017 For personal use only Regulatory - Uscom has prepared a new generation of products for approval and sale across multiple jurisdictions in 2017 New revenue 2017* USCOM 1A Uscom BP+ SpiroSonic CE (Europe) ✓ 2017 2017 FDA (USA) ✓ 2017 2017 CFDA (China) ✓ 2017 2017 TGA (Aus) ✓ 2017 2017 29
Slide 30: Revenue Targets
Revenue Targets For personal use only SpiroSonic – FY 2017 Total Revenue 20,000,000 18,000,000 16,000,000 BP+ - FY 2017 14,000,000 12,000,000 SpiroSonic $ 10,000,000 BP+ USCOM 8,000,000 USCOM 6,000,000 4,000,000 2,000,000 0 2015 2016* 2017* 2018* 2019* 2020* 30 $20m revenue by 2020 = 5 year CAGR of
Slide 31: Uscom – 2017
Uscom - 2017 For personal use only "Uscom has acquired global assets to ensure reliable revenue growth for investors for the coming decade. For 2017 our strategy is to deliver the devices we have acquired into global markets. We are confident that this will drive our revenue growth and underwrite lo
Slide 32: Annual Results – 2016
Annual Results – 2016 For personal use only ”Record growth for 2016, with two new revenue streams and CIIC distribution in 2017.” 32 Uscom – Medical devices the experts use
Slide 33: Thank You
Uscom (UCM) – Global Medical Devices For personal use only Annual Results FY 2016 Thank You Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Executive Chairman/CEO Uscom – Medical devices the exp
Slide 34: Business Background
Business Background For personal use only Premium noninvasive cardiovascular and pulmonary monitoring devices Addressing the growing threat of superbugs, heart failure, hypertension and asthma Validated, clinically accepted, cost and life saving devices with critical applications Aggressive
Slide 35: Products
Products For personal use only Multiple high fidelity noninvasive digital medical devices Fluid, Sepsis Hypertension & COPD & Heart Failure Vascular Health & Asthma US $1.3bn market * US $1.7bn market * US $400m market * CAGR of 7.6% * CAGR of 11.5% * CAGR of 6.5% * CE, FDA, TGA, CFDA
Slide 36: USCOM 1A Competitive Advantage
USCOM 1A Competitive Advantage For personal use only Non- SV beat Method Manufacturer Technology Rel+Rep invasive Simple Cost Portable to beat USCOM 1A Uscom Doppler ✓ ✓ ✓ ✓ ✓ ✓ BioZ Samsung BioImpedance ✗ ✓ ✓ ✗ ✓ ✗ NiCOM Cheetah BioReactance ✗ ✓ ✓ ✗ ✓ ✗ Nexfin Bmeye APP ✗ ✓ ✓ ✓ ✓ ✗ CardioQ Deltex D
Slide 37: Testimonials
Testimonials For personal use only “This machine is saving lives, there are no two ways about it.” Professor Brendan Smith, Anesthetist, Intensivist and Emergency Physician, N.S.W. Dept of Health, Australia “USCOM has changed the way I look at the cardiovascular status of my patients. It’s part of t
Slide 38: BP+ Competitive Advantage
BP+ Competitive Advantage For personal use only Uscom BP+ TensioMed BPLab IEM Centron AtCor Australia Hungary Russia Germany UK Australia USD 3,500 USD 6,000 USD 7,000 USD 7,000 USD 6,300 USD 20,000 1 min 2 min 2 min 2 min 1 min 1 min Stand-alone ABP, needs computer ABP, needs computer ABP, needs co
Slide 39: Why?
Why ? For personal use only Independent research from Cambridge University, Weill Cornell, University of California, Wales Heart Institute – BP+ = Four stars BP+ is on the international space station 36 McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson AB. Central blood pressure: current e
Slide 40: SpiroSonic Competitive Advantage
SpiroSonic Competitive Advantage For personal use only Uscom Welch Allyn Schiller Sibelmed Vitalograph MIR Carefusion NDD SpiroSonic Australia USA Switzerland Spain USA Italy USA Switzerland SpiroSonic SpiroPerfect Spirovit SP-1 Dataspir Touch Pneumotrac Spirodoc Microloop EasyOne PLus USD 1,890 USD
Slide 41: CPT Codes and Re-Imbursement
CPT Codes and Re-Imbursement For personal use only Product Measure Region Code Price (AUD) Status Uscom BP+ Central BP USA 93050 $25.60 S* USCOM 1A Cardiac Output USA 76999 $107.00 S** Cardiac Output China 310701023 $44.00 ✓ Cardiac Output China 220600010 $13.50 ✓ + $2.50 measure Cardiac Output Aust
Slide 42: Big Data
Big Data For personal use only Big data needs high quality sensors Uscom specialises in high quality non-invasive sensors • Software analytics • Telemetric signals • Cloud based processing/diagnosis • Personalised clinical advice • Medication and dosage • Serial monitoring • Multiple measures • Home